Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$20,577,126
in 17 filings, $20.2M under 10b5-1 plans

Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-01-16 mccormack riley 10% owner Sale −100,000 $0.75 $75K 2,100,000
2015-01-15 mccormack riley 10% owner Sale −125,000 $0.75 $94K 2,200,000
2015-01-14 mccormack riley 10% owner Sale −125,000 $0.79 $99K 2,325,000
2015-01-07 mccormack riley 10% owner Sale −200,000 $0.87 $174K 2,450,000
2015-01-06 mccormack riley 10% owner Sale −200,000 $0.92 $184K 2,650,000
2015-01-05 mccormack riley 10% owner Sale −150,000 $0.97 $146K 2,850,000
2014-02-04 mccormack riley 10% owner Purchase +1,000,000 $1.70 $1.7M 3,000,000
2014-02-04 mccormack riley 10% owner Purchase · Warrant to purchase common stock +250,000 250,000

Page 1 of 1 · 8 trades